- Home
- CDIO
as 12-18-2024 4:00pm EST
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 12.3M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 12.3M |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.19 - $3.56 | Next Earning Date: | 11-13-2024 |
| Revenue: | $35,688 | Revenue Growth: | 180.90% |
| Revenue Growth (this year): | 2093.61% | Revenue Growth (next year): | 43.05% |
Latest Cardio Diagnostics Holdings Inc. Common stock News
CDIO Breaking Stock News: Dive into CDIO Ticker-Specific Updates for Smart Investing
Insider Monkey
15 hours ago
Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests
Business Wire
2 days ago
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
Simply Wall St.
a month ago
Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations
Business Wire
a month ago
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
Business Wire
3 months ago
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
ACCESSWIRE
3 months ago
Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests
Business Wire
5 months ago
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
Business Wire
6 months ago
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
Compare CDIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDIO Cardio Diagnostics Holdings Inc. Common stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.